| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/31/2006 | US20060195929 Soybean cultivar S040132 |
| 08/31/2006 | US20060195928 Soybean Cultivar 4328386 |
| 08/31/2006 | US20060195927 Soybean cultivar 1339013 |
| 08/31/2006 | US20060195926 Soybean cultivar 4441080 |
| 08/31/2006 | US20060195925 Seeds and plants produced by crossing the cultivar with itself or another soybean variety; hybrid soybean seeds by mutagenesis or transformation; soybean variety can be used in crosses with other soybean plants to produce first generation soybean hybrids with disease, insect, herbicide resistance |
| 08/31/2006 | US20060195924 Soybean cultivar S040131 |
| 08/31/2006 | US20060195923 Soybean cultivar 4929388 |
| 08/31/2006 | US20060195922 Soybean cultivar 4817034 |
| 08/31/2006 | US20060195921 Fruits of the genus capsium with improved taste and enhanced nutritional value |
| 08/31/2006 | US20060195920 Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine from clover, medic ryegrass or fescue |
| 08/31/2006 | US20060195919 Arabidopsis promoters |
| 08/31/2006 | US20060195917 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194950 separating antibodies from proteases; provide a mutated immunoglobulin-binding protein ligand that exhibits an improved stability at increased pH-values, and accordingly an improved tolerance to cleaning under alkaline conditions |
| 08/31/2006 | US20060194754 Detecting nucleotide sequence using gene expression of reporter molecule |
| 08/31/2006 | US20060194753 Agent for treating leishmania infections |
| 08/31/2006 | US20060194751 Streptococcus pyogenes antigens |
| 08/31/2006 | US20060194750 Methods and materials for modulating trpc4 |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
| 08/31/2006 | US20060194730 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 08/31/2006 | US20060194727 Prevention and reduction of blood loss |
| 08/31/2006 | US20060194319 Promoter substitution for immunoglobulin therapy |
| 08/31/2006 | US20060194317 Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing |
| 08/31/2006 | US20060194316 Stromal differentiated neuron-like cells for use in treatment of neurodegenerative, ischemic, spinal cord and ataxic disorders; tissue engineering; regenerative medicine |
| 08/31/2006 | US20060194315 Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway |
| 08/31/2006 | US20060194314 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 08/31/2006 | US20060194311 Lna-cpg conjugates |
| 08/31/2006 | US20060194304 Kit comprising sodium chloride, potassium chloride, guanidinium chloride, sodium perchlorate or other chaotropic salt; and a nonionic detergent of Triton, NP40, Tween, or Syperonic, or MOPS buffer; endotoxin-free; purification, centrifuging, chromatography, filtration; gene therapy |
| 08/31/2006 | US20060194295 Novel, esterase, fungus capable of producing the same and method for producing the same |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060194291 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 08/31/2006 | US20060194290 Polypeptide variants with altered effector function |
| 08/31/2006 | US20060194288 Nucleic acid molecules encoding endonucleases and methods of use thereof |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194285 Biological production of clavulanic acid and related compounds |
| 08/31/2006 | US20060194283 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194282 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 08/31/2006 | US20060194281 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents |
| 08/31/2006 | US20060194278 Process for producing glucose dehydrogenase |
| 08/31/2006 | US20060194277 Method for producing target proteins by deleting or amplifyingibpa and/or ibpb gene coding for inclusion body-associated proteins |
| 08/31/2006 | US20060194276 Specificity grafting of a murine antibody onto a human framework |
| 08/31/2006 | US20060194274 Method for producing ketocarotinoids in genetically modified, non-human organisms |
| 08/31/2006 | US20060194248 Method of measuring human CYP3A inducibility |
| 08/31/2006 | US20060194236 Genetically engineering preferential bacteria; obtain bacteria that is stable containing desirable output traits, transform with expression vector, monitor bacteria for intensified mutation activity |
| 08/31/2006 | US20060194234 Methods for identifying small molecules that bind specific RNA structural motifs |
| 08/31/2006 | US20060194233 Ligand of the protein "beacon" |
| 08/31/2006 | US20060194229 Cancer markers and detection methods |
| 08/31/2006 | US20060194219 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194203 Packing cell system for eb virus vector |
| 08/31/2006 | US20060194202 generate fewer side products because there is complete restriction enzyme cleavage of the ligated intermediates which also increases the yield of the correct product |
| 08/31/2006 | US20060194196 Novel surface protein (hbsag) variant of the hepatitis B virus |
| 08/31/2006 | US20060193876 Fusion proteins of Mycobacterium tuberculosis |
| 08/31/2006 | US20060193874 Vaccines for proliferative ileitis and methods of making and using the same |
| 08/31/2006 | US20060193867 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 08/31/2006 | US20060193858 Full-lenth, isolated polypeptide comprising a polypeptide sequence of human SRC-like adaptor protein |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193851 Human anti-factor IX/IXa antibodies |
| 08/31/2006 | US20060193848 Mammalian tumor susceptibility genes and their uses |
| 08/31/2006 | US20060193841 Method for the treatment of parkinson's disease |
| 08/31/2006 | US20060193833 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 08/31/2006 | US20060193832 Use of the sodium iodine symporter to effect uptake of iodine |
| 08/31/2006 | US20060193830 Raav vector compositions and methods for the treatment of choroidal neovascularization |
| 08/31/2006 | US20060193821 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
| 08/31/2006 | US20060193778 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 08/31/2006 | US20060191549 Modifying nicotine and nitrosamine levels in tobacco |
| 08/31/2006 | US20060191547 Modifying nicotine and nitrosamine levels in tobacco |
| 08/31/2006 | DE19952957B4 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 08/31/2006 | DE102005009219A1 New ribonuclease tandem enzyme, useful for treating tumors, comprising 2 ribonuclease units connected covalently through a peptide linker |
| 08/31/2006 | DE102005007499A1 Verfahren zur Herstellung von enantiomer angereicherten alpha-Hydroxyketonen Process for the preparation of enantiomerically enriched alpha-hydroxyketones |
| 08/31/2006 | CA2785161A1 Mutant aox 1 promoters |
| 08/31/2006 | CA2601932A1 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus |
| 08/31/2006 | CA2598992A1 Immunostimulatory oligonucleotides |
| 08/31/2006 | CA2598929A1 Hiv epitopes and pharmaceutical composition containing same |
| 08/31/2006 | CA2598823A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 08/31/2006 | CA2598805A1 Sperm cell separation methods and compositions |
| 08/31/2006 | CA2598547A1 Primate t-lymphotropic viruses |
| 08/31/2006 | CA2598514A1 Mutant aox 1 promoters |
| 08/31/2006 | CA2598475A1 Protein and its use in diagnosing alzheimer's disease |
| 08/31/2006 | CA2598436A1 Modulating plant alkaloids |
| 08/31/2006 | CA2598307A1 Expression cassettes for seed-preferential expression in plants |
| 08/31/2006 | CA2597845A1 Compositions and their uses directed to il-4r alpha |
| 08/30/2006 | EP1696234A1 Methods using O6-alkylguanine-DNA alkyltransferases |
| 08/30/2006 | EP1696039A2 Lactobacillus specific probes |
| 08/30/2006 | EP1696038A2 Isolating biological modulators from biodiverse gene fragment libraries |
| 08/30/2006 | EP1696037A2 Isolating biological modulators from biodiverse gene fragment libraries |
| 08/30/2006 | EP1696036A1 Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells |
| 08/30/2006 | EP1696035A2 Improved bacillus host cell |
| 08/30/2006 | EP1696034A1 Novel method of nucleic acid transfer |
| 08/30/2006 | EP1696033A2 Pseudomonas exotoxin A-like chimeric immunogens |
| 08/30/2006 | EP1696032A1 Methods and means for the production of hyaluronan in fungi |
| 08/30/2006 | EP1696031A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/30/2006 | EP1696027A1 Hla-dr-binding antigen peptide derived from wt1 |
| 08/30/2006 | EP1696026A1 Method of concentrating and purifying nucleic acid and apparatus therefor |
| 08/30/2006 | EP1696025A2 Screening methods for enzymes and enzyme kits |
| 08/30/2006 | EP1695986A2 Anti-erb B2 antibodies |
| 08/30/2006 | EP1695985A2 Humanized antibodies and methods for forming humanized antibodies |